{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:50:51Z","timestamp":1790686251076,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the 2020 Advanced Research Promotion Program of the United Graduate School of Agricultural Sciences, Kagoshima University"},{"name":"Grant-in-Aid for Scientific Research (C)  from MEXT, Japan.","award":["23K05130"],"award-info":[{"award-number":["23K05130"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Severe acute respiratory syndrome coronavirus 2 infects host cells through binding of the spike protein receptor-binding domain (RBD) to the human angiotensin-converting enzyme 2 receptor. In this study, the antiviral activity of 14 catechin derivatives was evaluated using a pseudovirus assay that emulates spike-mediated cell fusion. Of these, gallocatechin gallate, epigallocatechin gallate, epigallocatechin 3-(3\u2033-O-methyl) gallate, and epigallocatechin exhibit strong inhibitory effects on infection. A structural comparison of the compounds revealed that catechins with a pyrogallol-type B-ring configuration exhibited greater inhibitory effects than their catechol-type counterparts. Docking simulations demonstrated that the hydroxyl group at the 5-position of the B-ring forms a hydrogen bond with Gln493 on the spike RBD, thereby facilitating additional stabilizing interactions with adjacent residues, such as Tyr453. Although catechin bioavailability is low, the results of this study suggest that regular consumption or gargling may offer localized antiviral activity at mucosal surfaces, such as those found in the oral or nasal cavity, because the catechin concentrations used in the cell assays are similar to those observed in green tea (100\u00a0\u00b5M). This study underscores the potential of pyrogallol-type catechins to act as antiviral agents.<\/jats:p>","DOI":"10.1038\/s41598-026-41170-6","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T15:50:49Z","timestamp":1772293849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pyrogallol B-ring enhances catechin binding to the SARS-CoV-2 spike receptor-binding domain to inhibit interaction with ACE2"],"prefix":"10.1038","volume":"16","author":[{"given":"Futaba","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanako","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanji","family":"Ishimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozue","family":"Sakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Hama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Mitsutake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"41170_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271-280.e8 (2020).","journal-title":"Cell"},{"key":"41170_CR2","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang, J. et al. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. U. S. A. 117, 11727\u201311734 (2020).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"41170_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/0889311X.2024.2363756","volume":"30","author":"S St\u00e4b","year":"2024","unstructured":"St\u00e4b, S. et al. Up, up, down, down: The structural biology of the SARS-CoV-2 spike protein and how it cheats the immune system. Crystallogr. Rev. 30, 74\u2013117 (2024).","journal-title":"Crystallogr. Rev."},{"key":"41170_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2021","unstructured":"Jackson, C. B., Farzan, M., Chen, B. & Choe, H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23, 3\u201320 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"41170_CR5","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.1128\/AAC.05531-11","volume":"55","author":"CE Isaacs","year":"2011","unstructured":"Isaacs, C. E. et al. Digallate dimers of (\u2212)-epigallocatechin gallate inactivate herpes simplex virus. Antimicrob. Agents Chemother. 55, 5646\u20135653 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41170_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.antiviral.2014.09.009","volume":"111","author":"HC Huang","year":"2014","unstructured":"Huang, H. C. et al. (\u2212)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes. Antivir. Res. 111, 100\u2013111 (2014).","journal-title":"Antivir. Res."},{"key":"41170_CR7","doi-asserted-by":"publisher","first-page":"7806","DOI":"10.1128\/JVI.00896-14","volume":"88","author":"CC Colpitts","year":"2014","unstructured":"Colpitts, C. C. & Schang, L. M. A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans. J. Virol. 88, 7806\u20137817 (2014).","journal-title":"J. Virol."},{"key":"41170_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2014.11.001","volume":"113","author":"C Weber","year":"2015","unstructured":"Weber, C., Sliva, K., Von Rhein, C., K\u00fcmmerer, B. M. & Schnierle, B. S. The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection. Antivir. Res. 113, 1\u20133 (2015).","journal-title":"Antivir. Res."},{"key":"41170_CR9","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.jfma.2020.12.018","volume":"120","author":"C-Y Wu","year":"2021","unstructured":"Wu, C.-Y., Yu, Z.-Y., Chen, Y.-C. & Hung, S.-L. Effects of epigallocatechin-3-gallate and acyclovir on herpes simplex virus type 1 infection in oral epithelial cells. J. Formos. Med. Assoc. 120, 2136\u20132143 (2021).","journal-title":"J. Formos. Med. Assoc."},{"key":"41170_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0166-3542(02)00212-7","volume":"58","author":"JM Weber","year":"2003","unstructured":"Weber, J. M., Ruzindana-Umunyana, A., Imbeault, L. & Sircar, S. Inhibition of adenovirus infection and adenain by green tea catechins. Antivir. Res. 58, 167\u2013173 (2003).","journal-title":"Antivir. Res."},{"key":"41170_CR11","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.001574","volume":"102","author":"L Henss","year":"2021","unstructured":"Henss, L. et al. The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection. J. Gen. Virol. 102, 1574 (2021).","journal-title":"J. Gen. Virol."},{"key":"41170_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17088-0","volume":"12","author":"EV LeBlanc","year":"2022","unstructured":"LeBlanc, E. V. & Colpitts, C. C. The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitor. Sci. Rep. 12, 12899 (2022).","journal-title":"Sci. Rep."},{"key":"41170_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26123572","volume":"26","author":"E Ohgitani","year":"2021","unstructured":"Ohgitani, E. et al. Significant inactivation of sars-cov-2 in vitro by a green tea catechin, a catechin-derivative, and black tea galloylated theaflavins. Molecules 26, 3572 (2021).","journal-title":"Molecules"},{"key":"41170_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10060721","volume":"10","author":"E Ohgitani","year":"2021","unstructured":"Ohgitani, E. et al. Rapid inactivation in vitro of sars-cov-2 in saliva by black tea and green tea. Pathogens 10, 721 (2021).","journal-title":"Pathogens"},{"key":"41170_CR15","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1007\/s00394-021-02681-2","volume":"60","author":"M Umeda","year":"2021","unstructured":"Umeda, M. et al. Preventive effects of tea and tea catechins against influenza and acute upper respiratory tract infections: A systematic review and meta-analysis. Eur. J. Nutr. 60, 4189\u20134202 (2021).","journal-title":"Eur. J. Nutr."},{"key":"41170_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23061295","author":"K Saeki","year":"2018","unstructured":"Saeki, K. et al. In vitro and in silico studies of the molecular interactions of epigallocatechin-3-o-gallate (egcg) with proteins that explain the health benefits of green tea. Molecules https:\/\/doi.org\/10.3390\/molecules23061295 (2018).","journal-title":"Molecules"},{"key":"41170_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2022.183999","volume":"1864","author":"L \u0160turm","year":"2022","unstructured":"\u0160turm, L. et al. Interactions of (\u2212)-epigallocatechin-3-gallate with model lipid membranes. Biochim. Biophys. Acta 1864, 183999 (2022).","journal-title":"Biochim. Biophys. Acta"},{"key":"41170_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2019.118023","volume":"230","author":"T Dai","year":"2020","unstructured":"Dai, T. et al. Analysis of inhibitory interaction between epigallocatechin gallate and alpha-glucosidase: A spectroscopy and molecular simulation study. Spectrochim. Acta A Mol. Biomol. Spectrosc. 230, 118023 (2020).","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"41170_CR19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s42003-025-07763-z","volume":"8","author":"J Revuelta","year":"2025","unstructured":"Revuelta, J. et al. Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity. Commun. Biol. 8, 360 (2025).","journal-title":"Commun. Biol."},{"key":"41170_CR20","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1021\/acs.jafc.4c11685","volume":"73","author":"Y Kato","year":"2025","unstructured":"Kato, Y. et al. Tea catechins in green tea inhibit the activity of SARS-CoV-2 main protease via covalent adduction. J. Agric. Food Chem. 73, 4116\u20134125 (2025).","journal-title":"J. Agric. Food Chem."},{"key":"41170_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81462-7","volume":"11","author":"AB Jena","year":"2021","unstructured":"Jena, A. B., Kanungo, N., Nayak, V., Chainy, G. B. N. & Dandapat, J. Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: Insights from computational studies. Sci. Rep. 11, 2043 (2021).","journal-title":"Sci. Rep."},{"key":"41170_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"J Shang","year":"2020","unstructured":"Shang, J. et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221\u2013224 (2020).","journal-title":"Nature"},{"key":"41170_CR23","doi-asserted-by":"publisher","first-page":"12860","DOI":"10.1021\/acs.jpcb.5b08737","volume":"119","author":"D Botten","year":"2015","unstructured":"Botten, D., Fugallo, G., Fraternali, F. & Molteni, C. Structural properties of green tea catechins. J. Phys. Chem. B 119, 12860\u201312867 (2015).","journal-title":"J. Phys. Chem. B"},{"key":"41170_CR24","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1271\/bbb.61.1434","volume":"61","author":"R Seto","year":"1997","unstructured":"Seto, R., Nakamura, H., Nanjo, F. & Hara, Y. Preparation of epimers of tea catechins by heat treatment. Biosci. Biotech. Biochcm 61, 1434\u20131439 (1997).","journal-title":"Biosci. Biotech. Biochcm"},{"key":"41170_CR25","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/jsfa.1597","volume":"83","author":"JZ Xu","year":"2003","unstructured":"Xu, J. Z., Leung, L. K., Huang, Y. & Chen, Z. Y. Epimerisation of tea polyphenols in tea drinks. J. Sci. Food Agric. 83, 2412\u20132419 (2003).","journal-title":"J. Sci. Food Agric."},{"key":"41170_CR26","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s11418-011-0515-0","volume":"65","author":"RA Wulandari","year":"2011","unstructured":"Wulandari, R. A. et al. New phenolic compounds from Camellia sinensis L. leaves fermented with Aspergillus sp. J. Nat. Med. 65, 584\u2013597 (2011).","journal-title":"J. Nat. Med."},{"key":"41170_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5630838","volume":"2020","author":"M Jang","year":"2020","unstructured":"Jang, M. et al. Tea polyphenols EGCG and theaflavin inhibit the activity of SARS-CoV-2 3CL-protease in vitro. Evid. Based Complement. Alternat. Med. 2020, 5630838 (2020).","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"41170_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-022-05059-1","volume":"28","author":"B Shahbazi","year":"2022","unstructured":"Shahbazi, B., Mafakher, L. & Teimoori-Toolabi, L. Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: An in silico study. J. Mol. Model. 28, 82 (2022).","journal-title":"J. Mol. Model."},{"key":"41170_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106499","volume":"59","author":"E Muturi","year":"2021","unstructured":"Muturi, E. et al. Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice. Int. J. Antimicrob. Agents 59, 106499 (2021).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"41170_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4103\/ijmr.IJMR_1132_20","volume":"153","author":"S Behera","year":"2021","unstructured":"Behera, S., Mahapatra, N., Tripathy, C. & Pati, S. Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach. Indian J. Med. Res. 153, 132 (2021).","journal-title":"Indian J. Med. Res."},{"key":"41170_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-20542-0","volume":"12","author":"G Kokic","year":"2021","unstructured":"Kokic, G. et al. Mechanism of SARS-CoV-2 polymerase stalling by remdesivir. Nat. Commun. 12, 1\u20137 (2021).","journal-title":"Nat. Commun."},{"key":"41170_CR32","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s12033-021-00358-z","volume":"63","author":"I Navabshan","year":"2021","unstructured":"Navabshan, I. et al. Computational lock and key and dynamic trajectory analysis of natural biophors against COVID-19 spike protein to identify effective lead molecules. Mol. Biotechnol. 63, 898 (2021).","journal-title":"Mol. Biotechnol."},{"key":"41170_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bbrc.2020.12.106","volume":"591","author":"WC Chiou","year":"2022","unstructured":"Chiou, W. C. et al. The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease. Biochem. Biophys. Res. Commun. 591, 130\u2013136 (2022).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"41170_CR34","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.ijbiomac.2020.07.235","volume":"164","author":"O Abian","year":"2020","unstructured":"Abian, O. et al. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. Int. J. Biol. Macromol. 164, 1693\u20131703 (2020).","journal-title":"Int. J. Biol. Macromol."},{"key":"41170_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13578-021-00680-8","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor. Cell Biosci. 11, 168 (2021).","journal-title":"Cell Biosci."},{"key":"41170_CR36","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","volume":"20","author":"MM Lamers","year":"2022","unstructured":"Lamers, M. M. & Haagmans, B. L. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol. 20, 270\u2013284 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"41170_CR37","doi-asserted-by":"publisher","first-page":"10534","DOI":"10.1039\/D0FO02442B","volume":"11","author":"T Nagasawa","year":"2020","unstructured":"Nagasawa, T., Ishimaru, K., Higashiyama, S., Hama, Y. & Mitsutake, S. Teadenol A in microbial fermented tea acts as a novel ligand on GPR120 to increase GLP-1 secretion. Food Funct. 11, 10534\u201310541 (2020).","journal-title":"Food Funct."},{"key":"41170_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215822","volume":"14","author":"N Nao","year":"2019","unstructured":"Nao, N. et al. Consensus and variations in cell line specificity among human metapneumovirus strains. PLoS ONE 14, e0215822 (2019).","journal-title":"PLoS ONE"},{"key":"41170_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/jb\/mvy017","volume":"164","author":"T Nagasawa","year":"2018","unstructured":"Nagasawa, T. et al. Phytosphingosine is a novel activator of GPR120. J. Biochem. 164, 27\u201332 (2018).","journal-title":"J. Biochem."},{"key":"41170_CR40","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450\u2013454 (2003).","journal-title":"Nature"},{"key":"41170_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S1471-4914(03)00133-3","volume":"9","author":"C Drosten","year":"2003","unstructured":"Drosten, C., Preiser, W., G\u00fcnther, S., Schmitz, H. & Doerr, H. W. Severe acute respiratory syndrome: Identification of the etiological agent. Trends Mol. Med. 9, 325\u2013327 (2003).","journal-title":"Trends Mol. Med."},{"key":"41170_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The protein data bank. Nucleic Acids Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"key":"41170_CR43","first-page":"8","volume":"40","author":"W Delano","year":"2002","unstructured":"Delano, W. The PyMOL molecular graphics system. CCP4 Newsl. Protein Crystallogr. 40, 8\u201316 (2002).","journal-title":"CCP4 Newsl. Protein Crystallogr."},{"key":"41170_CR44","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J. Comput. Chem. 31, 455 (2010).","journal-title":"J. Comput. Chem."},{"key":"41170_CR45","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim, S. et al. PubChem substance and compound databases. Nucleic Acids Res. 44, D1202\u2013D1213 (2016).","journal-title":"Nucleic Acids Res."},{"key":"41170_CR46","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","volume":"17","author":"TA Halgren","year":"1996","unstructured":"Halgren, T. A. Performance of MMFF94*. Scope, Parameterization, J. Comput. Chem. 17, 490\u2013519 (1996).","journal-title":"Scope, Parameterization, J. Comput. Chem."},{"key":"41170_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2022.102186","volume":"50","author":"M Akishino","year":"2022","unstructured":"Akishino, M. et al. Red algae-derived isofloridoside activates the sweet taste receptor T1R2\/T1R3. Food Biosci. 50, 102146 (2022).","journal-title":"Food Biosci."},{"key":"41170_CR48","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1002\/2211-5463.13301","volume":"11","author":"T Nagasawa","year":"2021","unstructured":"Nagasawa, T. et al. The molecular mechanism of phytosphingosine binding to FFAR4\/GPR120 differs from that of other fatty acids. FEBS Open Bio. 11, 3081\u20133089 (2021).","journal-title":"FEBS Open Bio."},{"key":"41170_CR49","first-page":"1","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open Babel: An open chemical toolbox. J. Cheminform. 3, 1\u201314 (2011).","journal-title":"J. Cheminform."},{"key":"41170_CR50","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X","volume":"20","author":"TAMMFFVI Halgren","year":"1999","unstructured":"Halgren, T. A. M. M. F. F. V. I. MMFF94s option for energy minimization studies. J. Comput. Chem. 20, 720\u2013729 (1999).","journal-title":"J. Comput. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41170-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41170-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41170-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:03:41Z","timestamp":1775559821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41170-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41170"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41170-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6766643\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11413"}}